19.07.13 Life Sciences sector in Canada
Canada maintains 583 core biotechnology development companies and over 200 public sector institutions in the biotechnology field. It is considered the third largest biotechnology market in the world after the US and the UK.
Latest overview of market potential of the Life Sciences and Healthcare sector in Mexico.
iCareHealth was set up in Australia in 2002 to help organise the many aspects of social and domiciliary care and cut down on the amount of time carers spend doing paperwork.
Forward-thinking UK companies are adapting their business models, products and processes to gain traction in overseas markets
The UK is a global leader in stratified medicine, putting the patient first as well as opening up the rich data and research resources of the National Health Service (NHS)
Howard is a highly-qualified healthcare management professional with over 30 years’ experience of public and private sector healthcare throughout the UK and in more than 65 countries worldwide, advising on health services management and strategic health sector reform.
The UK Government is committed to creating the ideal business environment to ensure overseas companies continue to invest in the UK life science industry.
The UK is committed to making clinical study start-up more efficient, introducing the Health Research Authority to streamline approvals for clinical research and new performance metrics for patient recruitment.
The UK Government is committed to ensuring there is a step change in the research activities and adoption of new products into the NHS.
UK science is informed by real world data and information, from bioresources to anonymised patient records, clinical practice, and outcomes data.